Who funds neurodegenerative disease research?

We count 248 funded neurodegenerative disease projects, active between 2019 and 2034, from 6 funders. The most came from EU · ERC (62 projects), EU · MSCA (48 projects) and Wellcome (37 projects). The median award is $2.6M, across the 230 of 248 projects that list an amount.

Funded projects

248

Funders

6

Median award

$2.6M

Open calls now

2

Top funders of neurodegenerative disease research

Projects whose title or summary mentions neurodegenerative disease. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open neurodegenerative disease funding calls

2 open calls mention neurodegenerative disease today.

• Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN): Powering the Next Generation of Research
  Alzheimer's AssociationNot specifiedDeadline: October 30, 2026 ·
• Clinical trials for advancing innovative interventions for neurodegenerative diseases
  European Commission · Horizon EuropeUp to €10,000,000Deadline: February 17, 2027 ·

Funded neurodegenerative disease projects

A sample, latest start first, at most three per program.

• Harmful R-loops: from molecular mechanisms to human disease
  Wellcome · £2,037,970 · ends 2034
• Does menopause enhance Alzheimer’s Disease risk by exacerbating vascular dysfunction?
  Wellcome · £1,686,636 · ends 2033
• ASCEND-HD: Advancing Support and Care for Emotional Needs and Distress in Huntington's Disease
  Wellcome · £1,960,148 · ends 2033
• Nonhuman Primate-Derived Enhancers for Studying Neural Circuit Functions
  NIH · NIMH · $4,028,357 · ends 2031
• CAREER: Engineering and In Vitro Evolution of XNAs as a Platform for Protein Recognition and Aggregation Control
  NSF · MPS · $838,813 · ends 2031
• National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
  NIH · NIA · $14,341,619 · ends 2031
• Our studies will support human space exploration by contributing the first biodosimetry for quantifying brain dna instability and…
  NASA · $45,000 · ends 2031
• Using Enhancer-directed expression within AAVs to target subtypes within the four major neuromodulatory populations
  NIH · NIMH · $3,312,425 · ends 2031
• From Molecules To Complex Syndromes: Using Networks to Understand Heterogeneity in FTD-TDP and Aging
  NIH · NIA · $3,215,718 · ends 2030
• ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)
  NIH · NIA · $17,009,244 · ends 2030

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “neurodegeneration or neurodegenerative”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.